Contraception on the NP Boards: Estrogen Contraindications, ACHES, and High-Yield Pearls

Pregnancy test strip and estrogen pills

Last updated: July 2026 — Reviewed by Shaira Cohen, MSN, APRN, FNP-C, CNE

When you sit down for your AANP or ANCC board exam, contraception NP boards content is going to make a major appearance in the women's health domain. Both exams aren't testing whether you know what a pill does — they're testing your ability to screen for safety, manage special populations, and catch the patient history detail that makes a "normal" prescription dangerous.

This guide breaks down the highest-yield contraception concepts from The Cohen Review archives: absolute estrogen contraindications, the ACHES warning-sign acronym, the non-estrogen alternatives, emergency contraception timing, and the special-population traps examiners love.

What Do the NP Boards Actually Test on Contraception?

Board questions on contraception almost always follow the same pattern: a patient history detail (age, smoking, migraine type, BMI, postpartum status, breastfeeding) that changes which method is safe. The exam is rarely asking "what does this drug do" — it's asking "can this specific patient take it."

Three things drive nearly every contraception question:

• Estrogen safety screening — does this patient's history make estrogen dangerous?
• Method selection — when estrogen is out, what's the right non-estrogen option?
• Timing and thresholds — the exact cutoffs (days postpartum, hours after intercourse, cigarettes per day) that separate a safe answer from a wrong one.

Key point for boards: If a question gives you a specific number — age, BMI, cigarettes per day, days postpartum — that number is almost always the point of the question. Don't skim past it.

Estrogen Contraindications: The #1 Tested Contraception Topic

If you remember nothing else from this breakdown, remember this: estrogen is pro-thrombotic (clot-forming). The boards love to give you a patient who wants a combined oral contraceptive (COC) but has a history that makes estrogen unsafe.

Absolute Contraindications (U.S. MEC Category 4 — Never Prescribe Estrogen)

• Smokers age 35 or older who smoke 15 or more cigarettes per day. This is the exact cutoff examiners test — see the callout below, because this one is frequently taught wrong.
• Migraine with aura, at any age. Migraine with aura significantly elevates stroke risk and is an absolute contraindication regardless of the patient's age.
• Uncontrolled or severe hypertension (systolic ≥160 mmHg or diastolic ≥100 mmHg, or hypertension with vascular disease). Estrogen further elevates blood pressure and compounds stroke/MI risk.
• History of venous thromboembolism (VTE) — any past deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, or known thrombogenic mutation.
• Current breast cancer, or breast cancer within the past 5 years. Estrogen can stimulate hormone-receptor-positive tumors.

Board Tip — the smoking cutoff is a classic trap: Many review sources teach "35 and smoking = automatic no," but the actual U.S. Medical Eligibility Criteria (MEC) draw the hard line at 15 cigarettes per day. A patient who is 35+ and smokes fewer than 15 cigarettes/day is U.S. MEC Category 3 (estrogen "usually not recommended" — avoid if a better alternative exists, but not an absolute contraindication). A patient who is 35+ and smokes 15 or more cigarettes/day is Category 4 (absolute contraindication). If an exam question gives you a specific cigarette count, that number is testing whether you know this distinction.

Also worth knowing: migraine without aura is generally acceptable under age 35 (Category 2), but becomes a caution once the patient turns 35 (Category 3) — age and aura status both matter, not just aura status alone.

Memorize the Warning Signs: The ACHES Acronym

Once a patient starts combined hormonal contraceptives, they need to know the warning signs of a dangerous thromboembolic event. The boards love to ask which symptoms require immediate emergency evaluation. Memorize this exact acronym:

• A — Abdominal Pain: Can indicate a blood clot in the pelvis or liver (mesenteric/hepatic vein thrombosis) or gallbladder disease.
• C — Chest Pain: Sharp, crushing chest pain or sudden shortness of breath can indicate a pulmonary embolism (PE) or myocardial infarction (MI).
• H — Headache: A sudden, severe headache — especially with weakness or numbness — signals a potential stroke.
• E — Eye Problems: Blurry vision, flashing lights, or sudden partial or complete vision loss can mean retinal vein thrombosis or stroke.
• S — Severe Leg Pain: Sudden unilateral pain, swelling, warmth, or redness in the calf or thigh indicates a deep vein thrombosis (DVT).

Key point for boards: ACHES symptoms are the answer whenever a question asks what to teach a patient being started on a combined hormonal method — pill, patch, or ring.

Non-Estrogen Alternatives: POPs, Depo-Provera, and IUDs

When estrogen is contraindicated, the next question is always "what do you switch to?" The answer is a progestin-only option.

Progestin-Only Pills (POPs / "The Mini-Pill")

The golden rule: traditional progestin-only pills (norethindrone) must be taken at the same time every day. If a patient is more than 3 hours late, she loses contraceptive coverage and needs a backup barrier method (condoms) for the next 48 hours.

Best for: breastfeeding patients (estrogen can reduce milk supply) and anyone who cannot tolerate estrogen.

Board Tip: Newer drospirenone-based POPs (e.g., Slynd) have a 24-hour missed-dose window instead of 3 hours. If a question specifies the drug name rather than just "the mini-pill," that detail matters — don't default to the 3-hour rule automatically.

Depo-Provera (Medroxyprogesterone Injection)

• Dosing: intramuscular or subcutaneous injection every 12 weeks (11–13 week window).
• The black box warning (highly tested): long-term use (greater than 2 years) is associated with loss of bone mineral density (BMD).
• Board tip: advise patients on Depo to get adequate calcium and vitamin D, engage in weight-bearing exercise, and consider transitioning to another method after 2 years of continuous use. Depo can also delay return to fertility by up to 10 months to a year after the last injection.

Intrauterine Devices (IUDs): Copper vs. Hormonal

The boards love to make you choose between the two IUD types based on patient history.

Method	Hormone-Free?	Duration	Best For
Progestin-Only Pill (POP)	No (progestin only)	Daily dosing	Breastfeeding; estrogen-intolerant patients
Depo-Provera (injection)	No (progestin only)	Every 12 weeks	Patients who want to avoid daily dosing; caution with long-term BMD loss
Hormonal IUD (e.g., Mirena, Kyleena)	No (progestin only, localized)	3–8 years (device-dependent)	Heavy menstrual bleeding; long-acting reversible contraception (LARC)
Copper IUD (Paragard)	Yes — fully hormone-free	Up to 10–12 years	Patients who want zero hormones; also first-line emergency contraception

[EXTERNAL LINK: CDC U.S. Medical Eligibility Criteria for Contraceptive Use, 2024]

Emergency Contraception: Timing, Efficacy, and the Obesity Effect

Levonorgestrel (brand name Plan B One-Step) is an emergency contraceptive pill that prevents pregnancy primarily by delaying or inhibiting ovulation.

• The time window: levonorgestrel is FDA-labeled for use within 72 hours (3 days) of unprotected intercourse, with effectiveness highest in the first 24 hours and declining steadily after that.
• Don't confuse this with ulipristal acetate. Some sources cite "efficacy up to 120 hours" for emergency contraception — but that 5-day window is the FDA-labeled and consistently effective range for ulipristal acetate (Ella), not levonorgestrel. Levonorgestrel's effectiveness drops off meaningfully after 72 hours; it is not reliably effective out to 120 hours the way ulipristal is. If an exam question specifies the 120-hour window, the correct drug is ulipristal, not Plan B.
• The obesity trap: oral emergency contraceptive pills are significantly less effective in patients with a BMI ≥ 30 kg/m². For these patients, a copper IUD (the single most effective form of emergency contraception, regardless of weight) or ulipristal acetate (Ella) are the preferred choices over levonorgestrel.

Special Populations: Postpartum, Breastfeeding, and Obesity

Expect these exact scenarios as case studies on your ANCC or AANP exam.

Postpartum and Breastfeeding

The board-tested rule is a hard cutoff, not a range you can round: combined estrogen-containing methods are absolutely contraindicated in the first 21 days postpartum for every patient, breastfeeding or not, because of elevated VTE risk immediately after delivery. From day 21 to 42, it depends on whether the patient has additional VTE risk factors (obesity, prior VTE, smoking, cesarean delivery, transfusion at delivery): no added risk factors is generally acceptable, added risk factors means avoid. After 42 days postpartum, combined methods are generally fine for everyone.

Breastfeeding patients specifically should default to a progestin-only method (POPs, the implant, or an IUD) in the early postpartum period regardless of the VTE timeline above, since estrogen can reduce milk supply.

Obesity and Oral Contraceptives

Increased adipose tissue alters the metabolism of standard hormonal contraceptives, and higher BMI is associated with reduced effectiveness of the pill, patch, and oral emergency contraception. If a patient has a high BMI, counsel toward long-acting reversible contraceptives (LARCs) — IUDs or the implant — which aren't affected by weight the same way.

The STI Catch

Hormonal pills, patches, injections, and IUDs do nothing to stop pathogens. Condoms are the only contraceptive method that also prevents sexually transmitted infections (STIs) — a detail examiners test by pairing a contraception question with an STI-risk history.

Applying It: A Board-Style Case Walkthrough

A 36-year-old woman who smokes 10 cigarettes per day asks for a combined oral contraceptive. Walk through the reasoning the way the exam expects:

1. Flag the risk factors: age ≥35 and a smoker — both estrogen red flags.
2. Apply the exact threshold: she smokes 10 cigarettes/day, which is under the 15/day cutoff. That makes her U.S. MEC Category 3 for combined methods — not an absolute contraindication, but generally avoided when a better option exists.
3. Choose the safer alternative: offer a progestin-only method (POP, Depo, implant, or hormonal IUD) instead of automatically refusing to prescribe anything.
4. Counsel on quitting smoking regardless of the method chosen, since smoking risk compounds with age either way.

This is the reasoning chain examiners are testing — not just "can she have estrogen," but "what specific number determines the answer, and what do you do instead."

Board-Style Practice Questions

1. A 37-year-old patient smokes 8 cigarettes per day and requests a combined oral contraceptive. According to U.S. MEC, what is the correct classification?

Show Answer

Answer: Category 3 (usually not recommended, not absolutely contraindicated). The absolute contraindication (Category 4) requires age ≥35 and ≥15 cigarettes/day. At 8 cigarettes/day, she falls into Category 3 — a progestin-only method is preferred, but this is not an automatic hard no the way it would be at ≥15 cigarettes/day.

2. A patient starting a combined oral contraceptive calls the clinic reporting sudden, severe unilateral calf pain and swelling. Which letter of the ACHES acronym does this represent, and what is the concern?

Show Answer

Answer: S — Severe Leg Pain, concerning for deep vein thrombosis (DVT). This patient needs immediate emergency evaluation, not a routine follow-up appointment.

3. A patient with a BMI of 34 kg/m² presents 60 hours after unprotected intercourse requesting emergency contraception. What is the most effective option?

Show Answer

Answer: Copper IUD. It is the single most effective emergency contraceptive option and its efficacy is not reduced by higher BMI, unlike oral levonorgestrel or ulipristal. Ulipristal acetate is a reasonable second-line oral option; levonorgestrel is the least preferred choice here given both the elevated BMI and the 60-hour window.

4. A patient is 25 days postpartum, formula-feeding, with no additional VTE risk factors, and wants to restart a combined oral contraceptive. Is this appropriate?

Show Answer

Answer: Generally acceptable (U.S. MEC Category 2). The absolute contraindication (Category 4) applies only to the first 21 days postpartum. Between 21 and 42 days, use is generally fine for a patient without additional VTE risk factors like obesity, prior VTE, or smoking.

FAQ

What are the absolute contraindications to estrogen-containing contraceptives?

Smokers age 35 or older who smoke 15 or more cigarettes per day, migraine with aura at any age, uncontrolled or severe hypertension, a history of venous thromboembolism or stroke, and current or recent (within 5 years) breast cancer are all absolute (U.S. MEC Category 4) contraindications to estrogen.

What does the ACHES acronym stand for?

ACHES stands for Abdominal pain, Chest pain, Headache, Eye problems, and Severe leg pain — the five warning signs of a thromboembolic event that require immediate emergency evaluation in a patient on combined hormonal contraceptives.

How long after unprotected intercourse is Plan B effective?

Levonorgestrel (Plan B) is FDA-labeled for use within 72 hours of unprotected intercourse, with the highest effectiveness in the first 24 hours. Ulipristal acetate (Ella) is the option labeled for consistent effectiveness through 120 hours, and a copper IUD is the most effective option overall, regardless of timing or BMI.

When can a postpartum patient safely start a combined oral contraceptive?

Never within the first 21 days postpartum, regardless of breastfeeding status, due to elevated VTE risk. From day 21 to 42, it depends on additional VTE risk factors like obesity, prior VTE, or smoking. After 42 days postpartum, combined methods are generally safe for everyone.

Why are progestin-only methods preferred for breastfeeding patients?

Estrogen can reduce milk supply, so progestin-only pills, the implant, or an IUD are the preferred contraceptive choices for breastfeeding patients, particularly in the early postpartum period.

Conclusion

Contraception questions on the AANP and ANCC boards reward precision, not general knowledge. Know the exact estrogen contraindications — especially the 15-cigarettes-per-day smoking threshold and migraine-with-aura rule — memorize ACHES cold, know when to reach for a non-estrogen alternative, and get the emergency contraception and postpartum timing windows exact rather than approximate.

Ready to lock this in before exam day? Work through timed women's health scenarios in The Cohen Review Question Bank, or build complete mastery with The Full Package board prep course.